Testing the waters – Efficacy of Bioresonance therapy in smoking cessation

Himanshu Gupta; Balwant singh Sidhu; Neeraj Mittal

Volume : VII, Issue : VI, June - 2017

Testing the waters – Efficacy of Bioresonance therapy in smoking cessation

Himanshu Gupta, Balwant Singh Sidhu, Neeraj Mittal

Abstract :

Aims: To compare the effects and relative clinical utility of Bioreasonance therapy, Bupropion and combination of Bioresonance therapy and Bupropion in the treatment of Nicotine dependant disorder patients. Settings and Design: A randomized open label parallel group prospective study was done in Psychiatry OPD. Methods and Material: 75 male nicotine dependent subjects were included in the study. These patients were divided into three groups and were given the following treatment regimes: Group A (25 patients) – Bioresonance therapy; Group B (25 patients) – Sustained release Bupropion tablet and Group C (25 patients) – combination of Bioresonance therapy and Bupropion. Severity of dependence symptoms was checked with Fagerstrom Test for Nicotine Dependence (FTND) scale at baseline, after 2 weeks and then at 12 weeks in all three groups. Statistical analysis used: Results were analysed by using chi square,Kruskal–Wallis Test. Friedman Test and Mann–Whitney Test. Results: Initially at 2 weeks, treatment regimes in both Group A and Group C were more effective as compared to that in Group B (p<0.05). But at 12 weeks, treatment regimes in both Group B and Group C were more effective as compared to that in Group A (p<0.05). Least number of dropouts was seen in Group C. Conclusions: Bioresonance therapy alone was not found to be effective in nicotine dependence. The only benefit of combination therapy was lesser dropouts as compared to other two regimes.